Status:
UNKNOWN
Role of Biomarkers to Screen for Obstructive Sleep Apnea
Lead Sponsor:
Assiut University
Conditions:
Obstructive Sleep Apnea
Eligibility:
All Genders
Brief Summary
assess the relationship between obstructive sleep apnea and endocrine, inflammatory, and metabolic bio-markers in consecutively enrolled adult male patients with a clinical suspicion of obstructive sl...
Detailed Description
Obstructive sleep apnea (OSA) is a disorder with high prevalence, estimated to occur in 34% of men and 17% of women , afflicting more than 100 million adults worldwide. OSA is the third most common s...
Eligibility Criteria
Inclusion
- All patients with a clinical suspicion of obstructive sleep apnea enrolled to the investigator's chest department.
Exclusion
- Patients who previously treated as obstructive sleep apnea, or receiving opioid pain medications.
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04093102
Start Date
October 1 2019
End Date
October 1 2022
Last Update
September 17 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.